Acell, Inc. FDA Approvals

0 new drug approvals and 3 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product	What it is	Route	Decided
Cytal® Wound Matrix; Cytal® Burn Matrix510(k)Jul 11, 2024	—	510(k)Substantially Equivalent (Special)	Jul 11, 2024
MicroMatrix® UBM Particulate510(k)Jul 11, 2024	—	510(k)Substantially Equivalent (Special)	Jul 11, 2024
MicroMatrix® Flex510(k)Sep 22, 2023	—	510(k)Substantially Equivalent (Traditional)	Sep 22, 2023